For many founders, that buyer isn’t a trade acquirer. They’re already in the building.
The Management Buy Out (MBO) sits quietly in the background of most exit conversations. Founders mention it, then dismiss it. Too complicated. Too expensive for the team. Won’t get the right price. And so the conversation moves on.
Sometimes it can be seen as a fallback when other options e.g. a family transition fail. That can be true, but they can be a great option in their own right too, not just a contingency plan.
But what if the myths doing the dismissing aren’t true?
“My management team could never afford to buy me out”
This is the most common reason founders rule out an MBO without ever testing it. The assumption is that the management team needs to fund the acquisition largely from personal savings — and unless they’re unusually wealthy, that’s not realistic.
It isn’t how MBOs work.
Management teams typically contribute a meaningful but relatively modest equity stake — enough to demonstrate commitment and skin in the game, not enough to make the deal contingent on personal wealth. The rest of the funding comes from a combination of sources: private equity or growth capital, asset-backed lending, mezzanine finance, and — critically — seller financing.
Which brings us to the next myth.
“Seller financing is a last resort”
In smaller MBOs, the founder providing part of the financing isn’t a sign that the deal couldn’t be done any other way. It’s often a deliberate structural choice — and one that can work significantly in the founder’s favour.
A loan note from the founder to the buying management team is a recognised instrument. The founder essentially defers a portion of their consideration, receiving it over time with interest. This can improve deal viability, reduce the management team’s external funding requirement, and in some structures, give the founder a better overall return than a clean cash deal at a lower headline price.
It also keeps the founder in a position of ongoing influence during the transition — something we’ll return to.
For founders who have never encountered this structure, it can feel counterintuitive. But it is widely used, particularly at the sub-£5 million deal level where institutional funding is harder to access. Understanding it as a tool — not a concession — changes the calculus entirely.
“Banks won’t touch an MBO at our size”
There is a funding gap in the market for smaller MBOs, and it’s worth being honest about that. Institutional private equity typically has a deal size floor that rules out most SME transactions. High street banks can be cautious. The funding landscape for a £1-3 million deal looks different from one at £10 million.
But the market is not empty. Asset-backed lenders, specialist debt funds, and regional growth finance providers all operate in this space. Vendor loan notes bridge the gap further. And in some deals, a combination of these instruments alongside modest management equity contribution makes the transaction workable without a single institutional funder.
The point is not that small MBOs are straightforward to finance. They are not. The point is that “the bank said no” is not the end of the conversation — it is the beginning of a different one.
“I’ll get a lower valuation than in a trade sale”
This one is partially true, and it’s worth being honest about that. The headline multiple in an MBO will typically be lower than a trade sale to a strategic buyer with genuine acquisition rationale. And you will usually receive less of it on day one — the structure of an MBO, with its mix of debt, deferred consideration and retained equity, means the full value takes time to materialise.
So why would any founder choose it?
Because the comparison with a trade sale is rarely as clean as the headline numbers suggest.
Trade deals frequently include earnouts — a portion of the consideration tied to the business hitting financial targets post-completion. In principle, a reasonable alignment mechanism. In practice, something quite different.
The corporate machine you’ve just joined has no particular interest in your earnout. The teams reviewing your targets had nothing to do with the deal. Other divisions will be looking to take credit for performance that touches your numbers. Some colleagues will feel threatened by your arrival. And the people with authority over your targets — applying them strictly, by the book, with no context and no goodwill — were never part of the conversation that set them.
Sometimes the squeeze is deliberate. More often it isn’t. But the outcome can be the same: you leave before the earnout completes, or you hit the targets on paper and find reasons are found not to pay. It happens more than anyone admits.
In an MBO, nobody can fire you or make you redundant. The people you’re negotiating with are the same people who need you to succeed. That changes everything about how the transition actually feels.
The flexibility argument nobody talks about
Here is what a well-structured MBO can offer that a trade sale almost never can: you control the pace.
You don’t have to exit in a single transaction. A partial MBO — selling a majority stake while retaining a minority — keeps you as a shareholder in a business you built, without the operational weight of running it day to day. That retained stake is not nothing. Depending on the business’s trajectory, it can become a meaningful pension asset or position you well for a future liquidity event when the management team itself seeks an exit.
You can also structure your own departure timeline. Step back gradually. Retain a board seat. Stay involved in strategy while the operations transition to the team you’ve backed.
And then there is the question of terms. You will almost certainly still have a non-compete clause in an MBO. But you will be negotiating it with people who know you, who understand your next chapter, and who have no interest in making your life difficult after you leave. That is a fundamentally different conversation from sitting across a table from a corporate acquirer’s legal team.
There is also something worth naming about continuity. In an MBO, you are not absorbed into an acquiring company. Your business does not disappear into a larger entity’s structure. The team that built it continues to run it. The culture you shaped has a chance to survive. For founders who care about legacy — and most do, even when they say they don’t — that matters.
“If they wanted to buy it, they’d have said something”
This is the quietest myth, and possibly the most damaging.
Management teams almost never initiate. Not because they aren’t interested. Not because they haven’t thought about it. But because the conversation is loaded with risk from their side: raise it too early and it looks presumptuous; raise it at the wrong moment and it looks opportunistic; raise it at all and you’ve shown your hand to the person who controls your career.
So they wait. And founders, reading the silence as disinterest, go looking for a trade buyer instead.
The conversation almost always has to start with the founder. Not as a negotiation, not as a formal proposal — but as a question. An open door. Have you ever thought about where this business goes next? What would it mean to you to own a piece of it?
You may be surprised by the answer.
What if you’re the reason the MBO never happened?
Not through malice or bad judgement. But because the myths felt like facts, the financing felt impossible, and the conversation felt like a risk not worth taking.
There is of course a risk in not talking to your management team. They might be interested in taking over, but don’t believe you might believe in them and they leave. We talk about that in our post “Why your best employee just left”.
MBOs are not the right route for every founder or every business. But they deserve to be genuinely considered — not ruled out before the conversation starts.
The question is worth asking. And in most cases, you’re the only one who can ask it.
At Exitologists, we work with founders across all exit routes — including MBOs. If you’re curious whether an MBO could work for your business, let’s talk.
